Previous scientific inquiries have revealed that DDX3X is extensively expressed in human CRC tissue and that suppressing this gene could increase the in vivo antitumor activity of antiviral nucleosides (AVNs) including AVN A25 [25]. Here, DDX3X is linked to colorectal carcinoma.